全球介入性神經放射學市場規模、佔有率、趨勢和成長分析報告（2026-2034年）

全球介入性神經放射學市場預計將從2025年的25.8億美元成長至2034年的46.7億美元，2026年至2034年的複合年成長率（CAGR）為6.79%。該市場正經歷顯著成長，主要得益於神經系統疾病盛行率的上升以及微創治療技術的進步。介入性神經放射學是指利用影像導引技術診斷和治療影響腦部、脊髓和血管系統的疾病。對具有更好臨床療效的微創治療的需求不斷成長，正在推動市場擴張。

關鍵促進因素包括中風、腦動脈瘤和血管畸形發生率的上升，以及影像診斷和導管介入技術的進步。醫療機構擴大採用先進設備，以提高手術精度並縮短患者康復時間。醫療基礎設施的擴張和人們對早期療育認知的提高也推動了全球市場的成長。

隨著診斷影像系統、機器人技術和神經血管器械的不斷創新，前景仍然光明。旨在改善治療效果和降低手術風險的研究活動有望​​創造新的機會。擴大神經專科護理的覆蓋範圍和深化臨床專業知識將進一步加速技術的普及應用。隨著對微創神經治療需求的成長，市場預計將保持強勁的成長動能。

我們的報告經過精心撰寫，旨在提供涵蓋廣泛行業和市場的全面且切實可行的洞察。每份報告都包含幾個關鍵組成部分，旨在幫助您全面了解市場環境：

市場概覽：本節提供清晰的市場概覽，包括關鍵定義、分類和當前產業格局。

市場動態：對影響市場成長的主要促進因素、限制因素、機會和挑戰進行詳細評估。這包括技術發展、法律規範和不斷變化的行業趨勢等因素。

市場區隔分析：本部分依據產品類型、應用、最終使用者和地區，將市場系統性地分類為若干關鍵細分市場。本部分揭示了每個細分市場的表現、成長潛力和市場貢獻。

競爭格局：我們對主要市場參與企業的市場定位、產品系列、策略舉措和財務表現進行了詳細評估。這為了解競爭趨勢和主要參與者所採取的策略提供了寶貴的見解。

市場預測：本預測是基於特定預測期內的市場規模和成長模式數據。本節結合歷史趨勢、當前市場狀況和定量分析，揭示未來預期趨勢。

區域分析：本部分全面回顧了主要地理區域的市場表現，確定了高成長領域和區域趨勢，從而更深入地了解區域市場機會。

新趨勢與新機會：識別關鍵市場趨勢、技術進步和新興投資機會。本部分重點在於潛在成長領域和未來產業趨勢。

客製化選項：我們提供靈活的客製化服務，可根據您的具體需求自訂報告。這包括額外的細分、特定國家/地區的分析、競爭對手分析、客製化資料點或專注於特定細分市場的洞察，以更好地支持您的策略決策。

目錄

第1章：引言

第2章執行摘要

第3章 市場變數、趨勢與框架

• 市場譜系展望
• 滲透率和成長前景分析
• 價值鏈分析
• 法律規範
  • 標準與合規性
  • 監管影響分析
• 市場動態
  • 市場促進因素
  • 市場限制因素
  • 市場機遇
  • 市場挑戰
• 波特五力分析
• PESTLE分析

第4章 全球介入性神經放射學市場：依設備類型分類

• 市場分析、洞察與預測
• 微導管
• 神經血管栓塞及彈簧圈置入輔助裝置
• 栓塞線圈
• 血液灌流裝置
• 液態栓塞劑
• 配件
• 微導管導引線

第5章 全球介入性神經放射學市場：依疾病分類

• 市場分析、洞察與預測
• 腦動脈瘤
• 顱內腫瘤
• 急性中風
• 其他疾病

第6章 全球介入性神經放射學市場：依最終用戶分類

• 市場分析、洞察與預測
• 醫院
• 門診手術中心
• 診斷中心

第7章 全球介入性神經放射學市場：按地區分類

• 區域分析
• 北美市場分析、洞察與預測
  • 美國
  • 加拿大
  • 墨西哥
• 歐洲市場分析、洞察與預測
  • 英國
  • 法國
  • 德國
  • 義大利
  • 俄羅斯
  • 其他歐洲國家
• 亞太市場分析、洞察與預測
  • 印度
  • 日本
  • 韓國
  • 澳洲
  • 東南亞
  • 其他亞太國家
• 拉丁美洲市場分析、洞察與預測
  • 巴西
  • 阿根廷
  • 秘魯
  • 智利
  • 其他拉丁美洲國家
• 中東和非洲市場分析、洞察與預測
  • 沙烏地阿拉伯
  • UAE
  • 以色列
  • 南非
  • 其他中東和非洲國家

第8章 競爭情勢

• 最新趨勢
• 公司分類
• 供應鏈和銷售管道合作夥伴（根據現有資訊）
• 市場佔有率和市場定位分析（基於現有資訊）
• 供應商情況（基於現有資訊）
• 策略規劃

第9章：公司簡介

• 主要公司的市佔率分析
• 公司簡介
  • Siemens Healthineers AG
  • GE HealthCare Technologies Inc
  • Medtronic PLC
  • Koninklijke Philips NV
  • Abbott Laboratories
  • Stryker Corporation
  • Bayer AG
  • Boston Scientific Corporation
  • Fujifilm Corporation
  • Terumo Corporation
  • Canon Medical Systems Corporation
  • Teleflex Incorporated
  • Merit Medical Systems Inc
  • Penumbra Inc
  • Biotronik SE & Co. KG

The global interventional neuroradiology market size is expected to reach USD 4.67 Billion in 2034 from USD 2.58 Billion in 2025, growing at a CAGR of 6.79 during 2026-2034.This market is experiencing substantial growth due to the increasing prevalence of neurological disorders and advancements in minimally invasive treatment techniques. Interventional neuroradiology involves image-guided procedures used to diagnose and treat conditions affecting the brain, spine, and vascular system. Growing demand for less invasive therapies with improved clinical outcomes is driving market expansion.

Key drivers include rising incidence of stroke, cerebral aneurysms, and vascular malformations, along with technological advancements in imaging and catheter-based interventions. Healthcare providers are increasingly adopting advanced devices that improve procedural precision and patient recovery times. Expanding healthcare infrastructure and growing awareness regarding early neurological intervention are also supporting market growth worldwide.

Future prospects remain promising as innovations in imaging systems, robotics, and neurovascular devices continue advancing. Research efforts aimed at improving treatment effectiveness and reducing procedural risks are expected to create new opportunities. Increasing access to specialized neurological care and expanding clinical expertise will further drive adoption. As demand for minimally invasive neurological treatments grows, the market is expected to maintain strong momentum.

Our reports are carefully developed to deliver comprehensive and actionable insights across a wide range of industries and markets. Each report includes several essential components designed to provide a complete understanding of the market environment:

Market Overview: This section provides a clear introduction to the market, including key definitions, classifications, and an overview of the current industry landscape.

Market Dynamics: A detailed evaluation of the primary drivers, restraints, opportunities, and challenges shaping market growth. It covers factors such as technological developments, regulatory frameworks, and evolving industry trends.

Segmentation Analysis: A structured breakdown of the market into key segments based on product type, application, end-user, and geographic region. This section highlights the performance, growth potential, and contribution of each segment.

Competitive Landscape: An in-depth assessment of leading market participants, including their market positioning, product portfolios, strategic initiatives, and financial performance. It provides valuable insights into competitive dynamics and the strategies adopted by key players.

Market Forecast: Data-driven projections of market size and growth patterns over a defined forecast period. This section incorporates historical trends, current market conditions, and quantitative analysis to illustrate expected future developments.

Regional Analysis: A comprehensive review of market performance across major geographic regions, identifying high-growth areas and regional trends to better understand localized market opportunities.

Emerging Trends and Opportunities: Identification of significant market trends, technological advancements, and new investment opportunities. This section highlights potential growth areas and future industry developments.

Customization Options: We offer flexible customization services to tailor reports according to specific client requirements. This may include additional segmentation, country-level analysis, competitor profiling, customized data points, or focused insights on particular market segments to better support strategic decision-making.

MARKET SEGMENTATION

By Device Type

• Microcatheters
• Neurovascular Embolization And Coiling Assist Devices
• Embolic Coils
• Flow Diversion Devices
• Liquid Embolic Agents
• Accessories
• Micro Guidewires

By Disease

• Cerebral Aneurysms
• Intra-Cranial Tumors
• Acute Strokes
• Other Diseases

By End Users

• Hospitals
• Ambulatory Surgical Centers
• Diagnostic Center

COMPANIES PROFILED

• Siemens Healthineers AG, GE HealthCare Technologies Inc., Medtronic PLC, Koninklijke Philips N.V., Abbott Laboratories, Stryker Corporation, Bayer AG, Boston Scientific Corporation, Fujifilm Corporation, Terumo Corporation, Canon Medical Systems Corporation, Teleflex Incorporated, Merit Medical Systems Inc., Penumbra Inc., Biotronik SE & Co. KG.

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL INTERVENTIONAL NEURORADIOLOGY MARKET: BY DEVICE TYPE 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Device Type
• 4.2. Microcatheters Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. Neurovascular Embolization And Coiling Assist Devices Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.4. Embolic Coils Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.5. Flow Diversion Devices Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.6. Liquid Embolic Agents Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.7. Accessories Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.8. Micro Guidewires Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL INTERVENTIONAL NEURORADIOLOGY MARKET: BY DISEASE 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast Disease
• 5.2. Cerebral Aneurysms Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. Intra-Cranial Tumors Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.4. Acute Strokes Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.5. Other Diseases Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL INTERVENTIONAL NEURORADIOLOGY MARKET: BY END USERS 2022-2034 (USD MN)

• 6.1. Market Analysis, Insights and Forecast End Users
• 6.2. Hospitals Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.3. Ambulatory Surgical Centers Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.4. Diagnostic Center Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL INTERVENTIONAL NEURORADIOLOGY MARKET: BY REGION 2022-2034 (USD MN)

• 7.1. Regional Outlook
• 7.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.2.1 By Device Type
  • 7.2.2 By Disease
  • 7.2.3 By End Users
  • 7.2.4 United States
  • 7.2.5 Canada
  • 7.2.6 Mexico
• 7.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.3.1 By Device Type
  • 7.3.2 By Disease
  • 7.3.3 By End Users
  • 7.3.4 United Kingdom
  • 7.3.5 France
  • 7.3.6 Germany
  • 7.3.7 Italy
  • 7.3.8 Russia
  • 7.3.9 Rest Of Europe
• 7.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.4.1 By Device Type
  • 7.4.2 By Disease
  • 7.4.3 By End Users
  • 7.4.4 India
  • 7.4.5 Japan
  • 7.4.6 South Korea
  • 7.4.7 Australia
  • 7.4.8 South East Asia
  • 7.4.9 Rest Of Asia Pacific
• 7.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.5.1 By Device Type
  • 7.5.2 By Disease
  • 7.5.3 By End Users
  • 7.5.4 Brazil
  • 7.5.5 Argentina
  • 7.5.6 Peru
  • 7.5.7 Chile
  • 7.5.8 Rest of Latin America
• 7.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.6.1 By Device Type
  • 7.6.2 By Disease
  • 7.6.3 By End Users
  • 7.6.4 Saudi Arabia
  • 7.6.5 UAE
  • 7.6.6 Israel
  • 7.6.7 South Africa
  • 7.6.8 Rest of the Middle East And Africa

Chapter 8. COMPETITIVE LANDSCAPE

• 8.1. Recent Developments
• 8.2. Company Categorization
• 8.3. Supply Chain & Channel Partners (based on availability)
• 8.4. Market Share & Positioning Analysis (based on availability)
• 8.5. Vendor Landscape (based on availability)
• 8.6. Strategy Mapping

Chapter 9. COMPANY PROFILES OF GLOBAL INTERVENTIONAL NEURORADIOLOGY INDUSTRY

• 9.1. Top Companies Market Share Analysis
• 9.2. Company Profiles
  • 9.2.1 Siemens Healthineers AG
  • 9.2.2 GE HealthCare Technologies Inc
  • 9.2.3 Medtronic PLC
  • 9.2.4 Koninklijke Philips N.V
  • 9.2.5 Abbott Laboratories
  • 9.2.6 Stryker Corporation
  • 9.2.7 Bayer AG
  • 9.2.8 Boston Scientific Corporation
  • 9.2.9 Fujifilm Corporation
  • 9.2.10 Terumo Corporation
  • 9.2.11 Canon Medical Systems Corporation
  • 9.2.12 Teleflex Incorporated
  • 9.2.13 Merit Medical Systems Inc
  • 9.2.14 Penumbra Inc
  • 9.2.15 Biotronik SE & Co. KG